Mrs Lisa Jan Bohne Clay, MED in Greenwood, AR - Psychologist

Mrs Lisa Jan Bohne Clay, MED is a Psychologist based in Greenwood, Arkansas. Mrs Lisa Jan Bohne Clay is licensed to practice in Arkansas (license number 9811E) and her current practice location is 2711 Shadow Lake Dr, Greenwood, Arkansas. She can be reached at her office (for appointments etc.) via phone at (479) 414-1703.

NPI number for Mrs Lisa Jan Bohne Clay is 1285812255 and her current mailing address is 2711 Shadow Lake Dr, Greenwood, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1285812255.

Contact Information

	Mrs Lisa Jan Bohne Clay, MED
	2711 Shadow Lake Dr, Greenwood, AR 72936
	(479) 414-1703
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Lisa Jan Bohne Clay
Gender	Female
Speciality	Psychologist
Location	2711 Shadow Lake Dr, Greenwood, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1285812255
Provider Enumeration Date: 02/01/2008
Last Update Date: 02/04/2008

Medical Identifiers

Medical identifiers for Mrs Lisa Jan Bohne Clay such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285812255	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	9811E (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Lisa Jan Bohne Clay is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Lisa Jan Bohne Clay, MED 2711 Shadow Lake Dr, Greenwood, AR 72936 Ph: (479) 414-1703	Mrs Lisa Jan Bohne Clay, MED 2711 Shadow Lake Dr, Greenwood, AR 72936 Ph: (479) 414-1703

News Archive

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

It happens to all of us at least once each winter in Montreal. You're walking on the sidewalk and before you know it you are slipping on a patch of ice hidden under a dusting of snow.

EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy

Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.

Direct link between fish consumption, brain structure and Alzheimer's risk

People who eat baked or broiled fish on a weekly basis may be improving their brain health and reducing their risk of developing mild cognitive impairment (MCI) and Alzheimer's disease, according to a study presented today at the annual meeting of the Radiological Society of North America.

Study discourages use of non-standard therapies for infantile spasms

Children with infantile spasms, a rare form of epileptic seizures, should be treated with one of three recommended therapies and the use of non-standard therapies should be strongly discouraged, according to a study of their effectiveness by a Weill Cornell Medicine and NewYork-Presbyterian investigator and collaborating colleagues in the Pediatric Epilepsy Research Consortium. Early treatment with an effective therapy is important for improving neurodevelopmental outcomes and, for some children, can result in permanent remission of epilepsy.

Positive phase III clinical trial data of NovoCure's NovoTTF device for recurrent GBM presented at ASCO

Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.

Psychologist in Greenwood, AR

Mary Katherine Clark, M.S.,LPE-I
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 320 N Main St, Greenwood, AR 72936
Phone: 479-996-1414

Mrs Lisa Jan Bohne Clay, MED - Psychologist in Greenwood, AR